bluebird bio Inc. (NASDAQ:BLUE) went down by -0.89% during the previous trading session, and it is maintaining the win ahead of Tuesday’s trading session. The share price of the Biotechnology giant went up by $64.90 to trade ended Tuesday trading at $65.48. This is down from the $65.48 price recorded on Monday’s trading session. Thanks to this latest performance, BLUE is closer to the higher price 52-week target of $215.00 and further from the lowest price target of $70.00. Its performance from the start of the year has also been negative, with BLUE down by -26.04% year-to-date.
bluebird bio Inc. (BLUE) started the day trading at $66.24 and recorded an intraday high of $66.87. It also recorded an intraday low of $64.58 during Tuesday’s trading session. bluebird bio Inc. is a very active stock that recorded a trading volume that is less than -35.9% of the average daily trading volume on Tuesday. The stock’s trading volume on Tuesday was 1096365, which is less than -35.9 of the total average daily trading volume of 1.49 million.
bluebird bio Inc. (NASDAQ:BLUE) 2020 Performance Impressive
The increase in BLUE’s stock price on Tuesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of BLUE currently stands at $143.98, which is higher than the current trading price of the stock by 54.92%. However, BLUE’s current trading price is -66.62% lower than the 52-week low price of $38.95. In terms of trading volume, bluebird bio Inc. currently experienced healthy participation during the last trading session. 1096365 shares of bluebird bio Inc. were traded on the stock exchange on Tuesday, which is less than -35.9% of the 1.49 million average trading volume of the stock.
The performance of the stock has been positive over the past year. BLUE’s performance over the past one year has seen it plunge by -45.00%, while the stock has gone down by -27.77% in the last six months. The quarterly performance of BLUE currently stands at 32.94%, and it is down by -2.82% in the last month. The only positive figure was from the weekly performance, which currently reads 2.85%. At the time of writing BLUE’s report, the company has a total market cap of $4.27B, making it one of the largest publicly-traded companies in the world.bluebird bio Inc. also has over 1153 employees all over the world.
BLUE Insider Activities
For bluebird bio Inc., insiders hold 90.80% of all company shares. The insider transactions over the past six months are up by 33.70%. During that period, insiders bought 112,241 shares in 15 transactions. In that same period, insiders sold 25,646 of their shares in 31 transactions. After these transactions, insiders at bluebird bio Inc. now hold 343.93k shares, which is over 109.96% of the total company stocks. Institutional investors currently hold a large chunk of the BLUE shares, as they control 0.62% of the company’s total stock.
BLUE Fundamental Analysis
For bluebird bio Inc., the stock’s diluted earnings per share (EPS) stands at -14.96. In the coming year, analysts expect the EPS to be -12.12. The stock’s EPS growth this year is -34.00%, -50.80% in the previous five years. In terms of revenue, bluebird bio Inc.’s quarterly sales (YOY) is shrinking at -2.64, which is higher than the average annual revenue of -50.80% over the past half a decade.
The Return on Investment (ROI) on bluebird bio Inc.’s stock currently stands at -63.40%. The gross margin of the company is 93.40%.
BLUE Analysts Prediction
and Evercore ISI reiterate their Outperform position on the stock ($86 and $100).
BLUE Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of BLUE currently stands at -0.06%, while the SMA50 is 8.43%. The biggest one is the SMA200, which is currently reading -13.87% ahead of Tuesday’s trading session. The Relative Strength Index of this stock is 52.65.